University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Publications in Food Science and
Technology

Food Science and Technology Department

June 2000

Fermentation of Fructooligosaccharides by Lactic Acid Bacteria
and Bifidobacteria
Handan Kaplan
University of Nebraska-Lincoln

Robert W. Hutkins
University of Nebraska-Lincoln, rhutkins1@unl.edu

Follow this and additional works at: https://digitalcommons.unl.edu/foodsciefacpub
Part of the Food Science Commons

Kaplan, Handan and Hutkins, Robert W., "Fermentation of Fructooligosaccharides by Lactic Acid Bacteria
and Bifidobacteria" (2000). Faculty Publications in Food Science and Technology. 13.
https://digitalcommons.unl.edu/foodsciefacpub/13

This Article is brought to you for free and open access by the Food Science and Technology Department at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in Food
Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, June 2000, p. 2682–2684
0099-2240/00/$04.00⫹0
Copyright © 2000, American Society for Microbiology. All Rights Reserved.

Vol. 66, No. 6

Fermentation of Fructooligosaccharides by Lactic Acid
Bacteria and Bifidobacteria†
HANDAN KAPLAN

AND

ROBERT W. HUTKINS*

Department of Food Science and Technology, University of Nebraska–Lincoln, Lincoln, Nebraska 68583-0919
Received 17 December 1999/Accepted 21 March 2000

Lactic acid bacteria and bifidobacteria were screened of their ability to ferment fructooligosaccharides
(FOS) on MRS agar. Of 28 strains of lactic acid bacteria and bifidobacteria examined, 12 of 16 Lactobacillus
strains and 7 of 8 Bifidobacterium strains fermented FOS. Only strains that gave a positive reaction by the agar
method reached high cell densities in broth containing FOS.
1-kestose (GF2), nystose (GF3), and 1F-fructofuranosyl nystose
(GF4). FOS have been self-affirmed by the manufacturers as
GRAS (generally recognized as safe) (19) and have been
added to infant formulas, yogurt, and other food products and
food supplements.
Despite the considerable commercial and research interests
in oligosaccharides and probiotic bacteria, relatively little is
known about which strains actually metabolize these materials.
Because commercial oligosaccharide preparations often contain glucose, fructose, sucrose, or other fermentable sugars, it
has been difficult to establish that growth in FOS-containing
medium is due to actual utilization of FOS (10, 11, 22). In this
study, we incorporated a pure form of FOS into MRS medium
in order to identify lactic acid bacteria and bifidobacteria capable of fermenting FOS.
A commercial FOS mixture containing three FOS species,
GF2 (32.0%), GF3 (53.6%), and GF4 (9.8%), was supplied by
The GTC Nutrition Company (Westminster, Colo.). The balance consisted of 2.3% glucose and fructose and 2.3% sucrose.
To prepare pure FOS, a 40% (wt/vol) FOS solution was applied to a column (30 by 5 cm) containing activated charcoal
(Sigma Chemical Co., St. Louis, Mo.). Glucose and fructose
were eluted by using distilled water, and sucrose was eluted by
the addition of 5% ethanol. Finally, FOS was eluted by using
15% ethanol, and the solution was lyophilized (FTS Systems,
Inc., Stone Ridge, N.Y.). The purity of the FOS and the concentration of each FOS moiety (GF2, GF3, and GF4) were
determined by high-pressure liquid chromatography (HPLC)
(Waters Corp., Milford, Mass.) using an Aminex HPX-42C
column (0.78 by 30 cm; Bio-Rad Laboratories, Hercules, Calif.) and an RI-410 detector (Waters). The column temperature
was kept constant at 85°C, and water was used as the mobile
phase at a flow rate of 0.6 ml/min.
An MRS-FOS agar medium was prepared by adding 2%
(wt/vol) purified FOS to MRS agar (3) containing 0.05% Lcysteine, 1.5% agar, and 30 mg of bromcresol purple per liter.
The MRS basal medium (i.e., MRS without carbohydrate) was
autoclaved, and the FOS was filter sterilized and then added to
the tempered agar. A total of 28 strains were evaluated, including 6 strains used as commercial probiotics (Table 1). Each
strain was initially grown in MRS broth and then diluted and
spread onto the MRS-FOS agar plates to give approximately
25 to 50 colonies. The plates were incubated anaerobically for
24 h. Strains that fermented FOS (and produced acid end
products) grew as colonies surrounded by a yellow zone (⬎3
mm) against a purple background. Nonfermenting colonies
produced smaller white colonies without a yellow zone. Thus,
although the basal MRS medium was sufficiently rich to pro-

The number of food and other dietary products containing
live Bifidobacterium and Lactobacillus bacteria has increased
significantly in recent years (20); this is due, in part, to the
beneficial effects these probiotic organisms are believed to
confer. Although substantial research efforts are currently in
progress to investigate these claims, the available evidence
indicates that ingestion of probiotic bacteria may promote desirable changes in the gastrointestinal tracts of humans and
other animals (8, 12, 13, 16). For example, ingestion of probiotic bacteria may reduce the severity and frequency of diarrheal diseases, as well as improve lactose digestibility among
lactose-intolerant individuals (6, 18).
The criteria established to select suitable Bifidobacterium
and Lactobacillus strains and to identify which strains possess
these desired traits are also the subject of much research interest. Several specific characteristics possessed by these bacteria are thought to be desirable or necessary (7). Probiotic
bacteria should resist low pH and survive gastric acidity, they
should tolerate bile salts at concentrations present in the intestinal tract, they should adhere to intestinal mucosal cells,
and they should provide clinically proven benefits. Recently, it
has been suggested that the ability of probiotic bacteria to
ferment oligosaccharides may be an especially important characteristic (1, 2, 4, 9, 14, 21). This is because the availability of
carbohydrates that escape metabolism and adsorption in the
small intestine have a major influence on the microflora that
become established in the colon. If certain carbohydrates, such
as oligosaccharides, are fermented only by specific strains of
bifidobacteria and lactobacilli, then diets containing so-called
“prebiotic” substrates could select for those strains of probiotic
bacteria. Such a scenario, if true, could be “one of the most
important stories to emerge in nutrition and gut microbiology
since the turn of the century” (9).
One specific group of oligosaccharides that has attracted
much commercial interest as prebiotics is the fructooligosaccharides (FOS). These compounds, which are marketed commercially as Raftilose and Nutraflora, can be obtained from
natural sources (e.g., inulin) or synthesized naturally from sucrose (2, 5, 15, 23). The FOS product Nutraflora belongs to the
latter category. It consists of a glucose monomer (G) linked
␣-1,2 to two or more ␤-2,1-linked fructosyl units (F), to give
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TABLE 1. FOS utilization by lactic acid bacteria and bifidobacteria
Organism

Sourcea

Growth on
MRS-FOSb

ODc

pHd

Lactobacillus bulgaricus B734
Lactobacillus bulgaricus CR5
Lactobacillus bulgaricus CR14
Lactobacillus acidophilus 33200
Lactobacillus acidophilus 837
Lactobacillus acidophilus DDS-1
Lactobacillus acidophilus NCFM
Lactobacillus plantarum 4008
Lactobacillus plantarum 1195
Lactobacillus plantarum 12006
Lactobacillus plantarum MR240
Lactobacillus lactis 448
Lactobacillus casei 685
Lactobacillus casei MR191
Lactobacillus strain GG
Streptococcus thermophilus 19987
Streptococcus thermophilus 14485
Streptococcus thermophilus 19258
Streptococcus thermophilus MTC321
Bifidobacterium adolescentis 15705
Bifidobacterium adolescentis 15706
Bifidobacterium breve 15698
Bifidobacterium breve 15700
Bifidobacterium bifidum 15696
Bifidobacterium infantis 17930
Bifidobacterium infantis 25962
Bifidobacterium longum 15708

NRRL
USU
USU
ATCC
ATCC
NC
NCSU
ATCC
NRRL
IFO
Rhodia
USU
UNL
Rhodia
ATCC
ATCC
ATCC
ATCC
Rhodia
ATCC
ATCC
ATCC
ATCC
ATCC
ATCC
ATCC
ATCC

⫺
⫺
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫺
⫹
⫹
⫺
⫺
⫺
⫺
⫺
⫹
⫹
⫹
⫹
⫺
⫹
⫹
⫹

0.5
0.5
2.6
1.4
1.8
1.5
1.6
2.8
1.9
2.4
2.4
0.8
1.9
2.4
0.5
0.6
0.7
0.6
0.7
1.3
1.3
1.8
1.6
0.8
1.7
1.8
1.4

6.3
6.4
4.5
4.5
4.1
4.4
4.3
4.5
4.0
4.4
4.6
5.6
4.9
4.0
5.9
5.4
5.7
5.5
5.9
4.6
4.5
4.4
4.6
5.0
4.4
4.4
4.6

a
NRRL, Northern Regional Research Laboratory, U.S. Department of Agriculture, Peoria, Ill.; USU, Utah State University, Logan, Utah; ATCC, American Type Culture Collection, Rockville, Md.; NC, Nebraska Cultures, Lincoln,
Nebr.; NCSU, North Carolina State University, Raleigh, N.C.; IFO, Institute for
Fermentation, Osaka, Japan; Rhodia, Rhodia Dairy Ingredients, Madison, Wis.;
UNL, University of Nebraska—Lincoln Culture Collection, Lincoln.
b
Growth on MRS-FOS agar was positive (⫹) if colonies were surrounded by
a yellow zone and negative (⫺) if no yellow zone was apparent.
c
Optical density (OD) at 625 nm after 24 h in MRS-FOS broth.
d
pH after 24 h in MRS-FOS broth.

mote colony formation by all of the 28 strains examined, only
the 19 strains that could ferment FOS produced enough acid to
cause a noticeable color change (Table 1). All of the Lactobacillus acidophilus strains fermented FOS, a result consistent
with that recently reported by Sghir et al. (17). Among the
FOS-fermenting L. acidophilus isolates were two strains,
DDS-1 and NCFM, that are widely promoted as probiotics.
Three other commercial probiotic strains, L. plantarum
MR240, L. casei MR191, and L. casei 685, also fermented
FOS, whereas Lactobacillus strain GG, one of the best-studied
probiotic strains, was found to be a nonfermenter. Interestingly, most of the L. bulgaricus and Streptococcus thermophilus
strains, ordinarily used for yogurt manufacture, were FOS nonfermenters.
To confirm that growth was dependent on FOS utilization,
strains were also inoculated into MRS basal broth containing
either 2% glucose, 2% commercial FOS or 2% purified FOS as
the carbohydrate source. To account for the glucose, fructose,
and sucrose in the commercial FOS, an equivalent amount of
these sugars was added to a set of control MRS broths to give
a final carbohydrate concentration of 0.1%. All strains, even
those previously identified as FOS nonfermenters, grew in
MRS-FOS broth, due apparently to the presence of background levels of carbohydrate in the basal MRS broth or, to a
limited extent, to contaminating sugars in the commercial FOS
(Table 1 and Fig. 1). However, final cell densities of FOS-

FIG. 1. Growth of B. infantis 17930 (A), L. acidophilus NCFM (B), and
Lactobacillus strain GG (C) in MRS broth containing either no added sugar (}),
2% glucose (Œ), 2% commercial FOS (F), or 2% pure FOS (■). To account for
the glucose, fructose, and sucrose in the commercial FOS, cells were also grown
in MRS broth containing equivalent amounts of these sugars ({).

fermenting Bifidobacterium infantis 17930 (Fig. 1A) and L.
acidophilus NCFM (Fig. 1B) were twice that of the FOS-nonfermenting Lactobacillus strain GG (Fig. 1C). We also observed that when L. acidophilus NCFM was first grown in MRS
broth (containing 2% glucose) and then transferred to MRSFOS broth, only a short lag phase occurred. In addition,
growth rates on FOS and glucose were the same. These results
suggest that FOS utilization did not require an induction period and that FOS was equally as good a substrate as glucose
in supporting growth.
That only FOS-fermenting strains consumed FOS was also
confirmed more directly by HPLC analysis of the fermentation
broths (Fig. 2). In these experiments, cultures were grown in
MRS-FOS broth containing 25 mM concentrations each of
GF2 and GF3 and 8 mM GF4. L. plantarum 1195, a FOS
fermenter, rapidly consumed GF2 and GF3 at near equal rates
and reduced the pH to below 4.0. Utilization of these saccharides by Lactobacillus strain GG was minimal, and the pH
decreased to only 6.0. Interestingly, none of the strains exam-
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FIG. 2. Utilization of FOS by L. plantarum 1195 (A) and Lactobacillus strain
GG (B). Cells were grown in MRS-FOS broth containing 25 mM GF2 (■), 25
mM GF3 (Œ), or 8 mM GF4 (}). The optical density (E) and pH (䊐) are also
shown.

ined were able to use the GF4 moiety. We are currently studying the molecular basis for FOS metabolism by these strains.
This research was supported, in part, by a grant from Dairy Management, Inc.
We thank The GTC Nutrition Company for providing the FOS. We
also thank Lisa Durso for reviewing the manuscript.
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